Esomeprazole and omeprazole may possibly enhance the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about amplified adverse effects like drowsiness, Even though the clinical relevance is minimal in most people – watch the client for adverse effects (e.If affected individual can not resume their standard oral med

Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects such as drowsiness, Even though the medical relevance is lower in many patients – observe the client for adverse effects (e.If patient are not able to resume their standard oral medication submit